TrialVaccine2023

Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study.

Romana Hosain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.